Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia

The role of cefepime for extended-spectrum β-lactamase (ESBL) bacteremia is unclear if susceptible in vitro. In a propensity score-matched study of patients with ESBL bacteremia, risk of death was 2.87 times higher for patients receiving cefepime compared with carbapenems (95% confidence interval [C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruibin, Cosgrove, Sara E., Tschudin-Sutter, Sarah, Han, Jennifer H., Turnbull, Alison E., Hsu, Alice J., Avdic, Edina, Carroll, Karen C., Tamma, Pranita D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942761/
https://www.ncbi.nlm.nih.gov/pubmed/27419191
http://dx.doi.org/10.1093/ofid/ofw132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942761/
https://www.ncbi.nlm.nih.gov/pubmed/27419191
http://dx.doi.org/10.1093/ofid/ofw132

Ejemplares similares